NOT KNOWN FACTS ABOUT RAVOXERTINIB

The overall boost in the risk of uterine cancer with tamoxifen use is very low (below 1%), and it goes back to standard inside a several years of halting the drug.Simply because tamoxifen functions like estrogen in the uterus, it could possibly increase your danger of cancers with the uterus, together with endometrial cancer and uterine sarcoma.